HSKA Financial Facts

Research and development: 322K
Other vaccines, pharmaceuticals and products: 5.43M
See Full Income Statement

Line of credit: 1.84M
Cash and cash equivalents: 5.75M
See Full Balance Sheet

Heska Corp. (HSKA) Earnings

  |   Expand Research on HSKA
Next EPS Date N/A EPS Growth Rate -860.0% *Last Qtr.
Average EPS % Beat Rate -973.3% Revenue Growth Rate 0.0% *Last Qtr.
Average % Move 1-Wk after EPS -5.7% Normal Earnings Time N/A
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/7/13 Q213 -$0.38-$0.01 -$0.37$18.3M$19.85M N/A Details
2/25/13 Q412 $0.07$0.09 -$0.02$18.5M$17.26M N/A Details
11/13/12 Q312 -$0.01$0.08 -$0.09$16.9M$19.7M N/A Details
8/10/12 Q212 $0.05$0.12 -$0.07$18.3M$19.82M N/A Details
2/17/12 Q411 $0.09N/A N/A $15.5M$15M N/A Details
7/27/11 Q211 N/A$0.00 N/A N/AN/A N/A N/A N/A
5/5/11 Q111 $0.17N/A N/A $16.44MN/A N/A Details